Sign in

You're signed outSign in or to get full access.

Patrick Kirwin

Director at ProMIS Neurosciences
Board

About Patrick Kirwin

Patrick D. Kirwin is an independent director of ProMIS Neurosciences (PMN), serving since June 29, 2015. He is a senior partner and founding partner at Kirwin LLP, a law firm; he was admitted to the Law Society of Alberta in 1983. Kirwin holds a BA in Economics from the University of Alberta and a JD from the University of Toronto Law School. Age 68; Alberta, Canada-based; independent under Nasdaq and Canadian rules .

Past Roles

OrganizationRoleTenureCommittees/Impact
Kirwin LLPSenior Partner; Founding PartnerAdmitted 1983; ongoing (not otherwise specified)Legal practice leadership and IP/trademarks; no PMN committee relevance disclosed

External Roles

OrganizationRoleTenureNotes
None reported among current directorsPMN discloses no other reporting-issuer board seats for Kirwin

Board Governance

  • Independence: Determined independent by PMN’s board under Nasdaq/Canadian rules .
  • Committee memberships (current as of April 16, 2025):
    • Audit Committee member (Chair: William Wyman; members: Wyman, Kirwin, Mandel‑Brehm) .
    • Corporate Governance and Nominating Committee member (Mandel‑Brehm, Kirwin, Wyman) .
    • Not a member of the Compensation Committee (members: Shafmaster, Wyman) .
  • Attendance (FY 2024): Board 6/6; Committee meetings 5/5 (Kirwin). PMN held 6 board meetings; all directors ≥75% attendance .
  • Lead Independent Director: Maggie Shafmaster .

Fixed Compensation

  • PMN’s non‑employee director policy (adopted Dec 2024): Annual board retainer $40,000; Committee retainers—Audit Chair $15,000; Audit member $7,500; Comp Chair $10,000; Comp member $5,000; Nominating Chair $8,000; Nominating member $4,000. Directors also receive equity awards (see next section) .
  • FY 2024 actuals for Patrick Kirwin:
ComponentFY 2024 Amount (USD)
Fees paid in cash$40,000
Option awards (grant-date fair value)$34,968
All other compensation$0
Total$74,968

Performance Compensation

  • Equity award framework for non‑employee directors (policy): Initial option grant 40,000 options on election; annual option grant 20,000 options at each annual meeting; potential re‑stake option grants; vesting: initial 25% at grant, remainder monthly over 3 years; annual options vest in full by next annual meeting; re‑stake: 1/3 at grant, remainder monthly over 2 years; full acceleration upon a “Triggering Event” under the plan .
  • Outstanding director options (as of Dec 31, 2024):
MetricKirwin (Shares/Units)
Shares underlying option awards (#)38,887
  • Performance metrics tied to director compensation: None disclosed (no revenue, EBITDA, TSR, or ESG targets for directors in proxy; directors compensated via retainers and time‑based option vesting) .

Other Directorships & Interlocks

Company/EntityRelationshipNotes
PMN Audit CommitteeMemberAudit committee report signed by Chair Wyman with members Kirwin and Mandel‑Brehm
PMN Corporate Governance & Nominating CommitteeMemberGovernance oversight (board effectiveness, nominations)
Compensation CommitteeNot a memberCommittee comprised of Shafmaster and Wyman
Other public boardsNone reportedPMN disclosure indicates remaining current directors (including Kirwin) are not directors of other reporting issuers

Expertise & Qualifications

  • Legal and governance expertise: Senior partner and founding partner at Kirwin LLP; Barrister & Solicitor (Alberta). Degrees: BA Economics (University of Alberta), JD (University of Toronto) .
  • Board experience: PMN director since 2015; service on Audit and Corporate Governance committees .

Equity Ownership

  • Beneficial ownership (as of April 16, 2025):
CategoryShares
Direct ownership52,145
Patrick D. Kirwin Professional Corporation41,331
Spouse7,648
Options exercisable within 60 days38,887
Warrants exercisable within 60 days14,333
Total beneficial ownership154,344
Ownership as % of outstanding<1% (asterisk in proxy table)
  • Hedging/pledging: PMN discloses there are no specific requirements preventing NEOs or directors from purchasing hedging instruments (e.g., collars/swaps) designed to offset decreases in PMN stock value (policy context; no individual hedging disclosed) .

Governance Assessment

  • Positives:

    • Independent director with strong legal background; sits on Audit and Governance committees, supporting oversight of financial reporting and board effectiveness .
    • Perfect attendance in 2024 across board and committee meetings (6/6 board; 5/5 committee), indicating high engagement .
    • Director equity awards provide alignment (time‑based vesting; annual awards), and ownership includes direct, professional corporation, and family holdings .
    • Compensation processes supported by an independent compensation consultant (Alpine Rewards) engaged by the Compensation Committee (independence assessed) .
  • Watch items / potential red flags:

    • PMN permits use of hedging instruments; absence of explicit director stock ownership guidelines is not disclosed—potential misalignment risk if hedging is used (no such use disclosed for Kirwin) .
    • Board‑level related‑party exposure exists via Chair Eugene Williams’s consulting agreement ($225,000/year), though not directly implicating Kirwin; still relevant to overall board independence perception .
    • PMN notes “no formal assessment procedure” for annual board/committee effectiveness, despite Governance Committee responsibility—process rigor may be a concern for investors focused on governance quality .
  • Overall: Kirwin’s independence, committee roles, and attendance support board effectiveness; equity participation indicates alignment. Investors should monitor PMN’s hedging policy and the chair’s consulting relationship for broader governance optics, while noting Kirwin is not party to related‑party transactions disclosed .